Cargando…
The race to treat COVID-19: Potential therapeutic agents for the prevention and treatment of SARS-CoV-2
The unforeseen emergence of coronavirus disease 2019 (COVID-19), a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at the Wuhan province of China in December 2019, subsequently its abrupt spread across the world has severely affected human life. In a short span of time, COVID-19 has sac...
Autores principales: | Shagufta, Ahmad, Irshad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802596/ https://www.ncbi.nlm.nih.gov/pubmed/33486200 http://dx.doi.org/10.1016/j.ejmech.2021.113157 |
Ejemplares similares
-
N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2
por: Poe, Francis L., et al.
Publicado: (2020) -
Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents
por: Kim, Cheorl-Ho
Publicado: (2021) -
Racing for a SARS‐CoV‐2 vaccine
por: Türeci, Özlem, et al.
Publicado: (2021) -
EGCG as an anti-SARS-CoV-2 agent: Preventive versus therapeutic potential against original and mutant virus
por: Tsvetkov, Vladimir, et al.
Publicado: (2021) -
Defensins: Therapeutic molecules with potential to treat SARS-CoV-2 infection
por: Banu, Sarena, et al.
Publicado: (2022)